Video wird geladen...

Video konnte nicht geladen werden

Beim Laden dieses Videos ist ein Problem aufgetreten. Dies könnte an einem vorübergehenden Netzwerkproblem liegen oder das Video ist möglicherweise nicht verfügbar.

🚨 DR. WILLIAM MAKIS’ IVERMECTIN DOSING GUIDE FOR CANCER & PREVENTION IS SPREADING FAST ONLINE Thousands are now discussing Dr. William Makis MD’s categorized Ivermectin dosing approach based on body weight (mg/kg/day) and cancer severity. Here’s the breakdown people keep sharing: LOW DOSE: ≤ 0.5 mg/kg/day Often discussed for:... • Remission support • Prevention strategies • Strong family cancer history ⚠️ Reports shared online describe minimal long term side effects at lower ranges. Access them via PharmacyinUSA MEDIUM DOSE: 1.0 mg/kg/day Most commonly discussed for: • Breast cancer • Lung cancer • Colon cancer • Pancreatic cancer • Renal cancers ⚠️ Supporters claim this is the “standard starting range” used in many repurposed drug discussions. HIGH DOSE: 2.0 mg/kg/day Typically discussed for: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers ⚠️ Some anecdotal reports mention temporary visual side effects at higher dosing ranges. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Usually discussed only for: • Advanced metastatic disease • Late stage aggressive cancers ⚠️ High dose use remains highly controversial and experimental. Quick weight example for a 60 kg (132 lb) adult: • Low: 30 mg/day • Medium: 60 mg/day • High: 120 mg/day • Very High: 150+ mg/day Why this conversation keeps exploding online: ✅ Ivermectin has decades of human use worldwide ✅ Growing interest in repurposed cancer drugs ✅ Observational and preclinical research continues expanding ✅ Patients are increasingly sharing personal experiences publicly. (Jase Medical) Still, millions are now asking why inexpensive repurposed drugs are generating so much public interest while receiving so little mainstream discussion. The chart has been upscaled for better visibility #Ivermectin #Fenbendazole #Mebendazoleshow more

PharmacyinUSA

24,144 subscribers

91,070 Aufrufe • vor 3 Monaten •via X (Twitter)

Gesundheit & Wellness Wissenschaft & Technologie

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!

🚨 THE IVERMECTIN DOSING CHART EVERYONE'S SHARING 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). 🟢 LOW DOSE (≤ 0.5 mg/kg/day) Often discussed for: • Remission support • Prevention strategies • Strong family history of cancer 🟡 MEDIUM DOSE (1.0 mg/kg/day) Most commonly discussed for: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Renal cancers • Gastric cancers This is the dose Dr. Makis frequently references as a starting point in cancer discussions. 🔴 HIGH DOSE (2.0 mg/kg/day) Often discussed for: • Leukemia • Brain cancers • Pancreatic cancers • Other highly aggressive cancers 🔴 VERY HIGH DOSE (≥ 2.5 mg/kg/day) Typically discussed only in: • Advanced metastatic disease • Extremely aggressive cancers • Situations where patients have exhausted conventional options For a 60 kg (132 lb) person: • Low Dose: ≤30 mg/day • Medium Dose: 60 mg/day • High Dose: 120 mg/day • Very High Dose: ≥150 mg/day The reason this chart keeps getting shared isn't because everyone agrees with it. It's because millions of people are now asking a question they never asked before: That's why the conversation around repurposed medicines keeps getting bigger. If you want access to ivermectin, fenbendazole, or mebendazole, then visit PharmacyinUSA today!

PharmacyinUSA

51,049 Aufrufe • vor 2 Monaten

IVERMECTIN: Cancer, Alzheimers & Parkinson’s and Parasites… FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day Best for: - Cancers in remission

IVERMECTIN: Cancer, Alzheimers & Parkinson’s and Parasites… FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day Best for: - Cancers in remission

Dr Maria Tenpenny

77,012 Aufrufe • vor 4 Tagen

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

🚨IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION Based on Dr. William Makis MD's commonly shared dosing framework Thousands of people reference this ivermectin dosing chart. Below is a simplified breakdown organized by body weight (mg/kg per day). 📌LOW DOSE ≤ 0.5 mg/kg/day Best For: • Cancers in remission • Strong family history or genetic predisposition • Preventive (prophylactic) use Reported Side Effects: • No long-term side effects reported Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer patient who received chemotherapy plus 12 mg ivermectin daily. After 2 months, the tumor marker CA125 fell from 288 to 22, and the tumor was reported to have disappeared. 📌MEDIUM DOSE 1.0 mg/kg/day Best For: • Starting dose for many cancers including: • Lung cancer • Pancreatic cancer • Renal cell carcinoma • Gastric cancer Reported Side Effects: • No long-term side effects reported Example: Dr. Shankara Chetty reported a 70-year-old prostate cancer patient with a PSA of 89 taking 45 mg daily (along with lactoferrin). After 2 months, PSA reportedly decreased to 10.9. 📌HIGH DOSE 2.0 mg/kg/day Best For: • Aggressive cancers • Leukemia • Pancreatic cancer • Brain cancers Reported Side Effects: • No long-term side effects reported Example: Dr. Allan Landrito reported a Stage 4 gallbladder cancer patient taking 2 mg/kg daily for 14 months, with the cancer reportedly disappearing. 📌VERY HIGH DOSE ≥ 2.5 mg/kg/day Best For: • Extensive metastatic disease • Extremely poor prognosis • Certain aggressive brain cancers Possible Side Effects: • Temporary visual disturbances • Usually, short lived and resolve within days Example: Dr. Shankara Chetty reported using 2.5 mg/kg/day in a patient with no side effects reported. #Ivermectin #MakisMD #Genixmeds

GENIX MEDS

31,182 Aufrufe • vor 2 Monaten

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day **Best for:** - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) **Side effects:** No long-term side effects reported. **Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day **Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.). **Side effects:** No long-term side effects reported. **Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day **Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers). **Side effects:** No long-term side effects reported. **Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day **Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. **Side effects:** Possible short-term & transient visual effects (usually resolve in a few days). **Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. **Quick conversion example (for a 60 kg / 132 lb person):** - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information. Follow for more .

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day Best for: - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) Side effects: No long-term side effects reported. Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day Best for: Starting dose for most cancers (lung, pancreatic, renal cell, gastric, etc.). Side effects: No long-term side effects reported. Example: Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day Best for: Very aggressive cancers (leukemia, pancreatic, brain cancers). Side effects: No long-term side effects reported. Example: Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Best for: Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. Side effects: Possible short-term & transient visual effects (usually resolve in a few days). Example: Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. Quick conversion example (for a 60 kg / 132 lb person): - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information. Follow for more .

mcgill_medicines

104,163 Aufrufe • vor 1 Monat

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day **Best for:** - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) **Side effects:** No long-term side effects reported. **Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day **Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.). **Side effects:** No long-term side effects reported. **Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day **Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers). **Side effects:** No long-term side effects reported. **Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day **Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. **Side effects:** Possible short-term & transient visual effects (usually resolve in a few days). **Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. **Quick conversion example (for a 60 kg / 132 lb person):** - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day Best for: - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) Side effects: No long-term side effects reported. Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day Best for: Starting dose for most cancers (lung, pancreatic, renal cell, gastric, etc.). Side effects: No long-term side effects reported. Example: Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day Best for: Very aggressive cancers (leukemia, pancreatic, brain cancers). Side effects: No long-term side effects reported. Example: Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Best for: Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. Side effects: Possible short-term & transient visual effects (usually resolve in a few days). Example: Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. Quick conversion example (for a 60 kg / 132 lb person): - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

Joe Tippens

136,159 Aufrufe • vor 2 Monaten

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day **Best for:** - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) **Side effects:** No long-term side effects reported. **Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day **Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.). **Side effects:** No long-term side effects reported. **Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day **Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers). **Side effects:** No long-term side effects reported. **Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day **Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. **Side effects:** Possible short-term & transient visual effects (usually resolve in a few days). **Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. **Quick conversion example (for a 60 kg / 132 lb person):** - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION 1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day). LOW DOSE: ≤ 0.5 mg/kg/day Best for: - Cancers in remission - Strong family history or genetic predisposition - Prophylaxis (preventive) Side effects: No long-term side effects reported. Example: Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished. MEDIUM DOSE: 1.0 mg/kg/day Best for: Starting dose for most cancers (lung, pancreatic, renal cell, gastric, etc.). Side effects: No long-term side effects reported. Example: Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9. HIGH DOSE: 2.0 mg/kg/day Best for: Very aggressive cancers (leukemia, pancreatic, brain cancers). Side effects: No long-term side effects reported. Example: Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared. VERY HIGH DOSE: ≥ 2.5 mg/kg/day Best for: Extensive metastatic disease, extremely poor prognosis, or certain brain cancers. Side effects: Possible short-term & transient visual effects (usually resolve in a few days). Example: Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported. Quick conversion example (for a 60 kg / 132 lb person): - Low: ≤30 mg/day - Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid) - High: 120 mg/day - Very High: ≥150 mg/day Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary. Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only. Share to spread awareness — information is power. 💊

Valerie Anne Smith

968,128 Aufrufe • vor 3 Monaten

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds

RXMEDS.STORE

353,990 Aufrufe • vor 1 Monat

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

GENIX MEDS

19,941 Aufrufe • vor 2 Monaten

After a year of intensive research, Dr. William Makis presents the most crucial graph of his career: the ivermectin dosing schedule for cancer. Dr. Makis recommends a starting dose of 1mg per kg of body weight per day for most cancers, including breast, colon, lung, pancreatic, renal, gastric, and leukemias. For a 60kg individual, this translates to 60mg daily, which can be taken as: - Five 12mg pills - Or 6ml of liquid (approximately one teaspoon plus 1ml) The evidence supporting the efficacy of ivermectin is compelling and dose-dependent. - Dr. Shankara Chetty observed a significant drop in a prostate cancer patient’s PSA from 89 to 11 after taking 45mg/day. - Dr. Tess Lawry’s case study showed a remarkable decrease in CA125 (an ovarian cancer marker) from 288 to 22 after just 0.2mg/kg. - A long-term Castro study on children with leukemia demonstrated no side effects after 6 months at a dose of 1mg/kg. For aggressive cancers like pancreatic and brain cancers, a higher dose may be necessary due to the blood-brain barrier. Dr. Makis cites examples: - Dr. Landrito’s colleague with terminal gallbladder cancer experienced the disappearance of cancer after 14 months at a dose of 2mg/kg/day. - The highest documented dose is 2.5mg/kg, as reported by Dr. Chetty, with only transient visual side effects that resolved. Mainstream oncology is unlikely to offer this treatment due to ivermectin’s generic, off-patent status and unprofitable nature. Consequently, there are no funded clinical trials. Dr. Makis concludes that using ivermectin in cancer treatment is straightforward and highly safe. He strongly suggests that those struggling with cancer should start with a dose of 1mg/kg/day. This can be taken for several months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight cancer may already be within your reach.

Commentary | Global Ivermectin Research Hub

102,157 Aufrufe • vor 4 Monaten

After a year of intensive research, Dr. William Makis presents the most critical graph of his career: the ivermectin dosing schedule for cancer. According to Dr. Makis, for most cancers - including breast, colon, lung, pancreatic, renal, gastric, and leukemias - a starting dose of 1mg per kg of body weight per day is recommended. For a 60kg individual, this equates to 60mg daily: - Five 12mg pills - Or 6ml of liquid (approx. one teaspoon + 1ml) The evidence for efficacy is compelling and dose-dependent: - Dr. Shankara Chetty saw a prostate cancer patient's PSA drop from 89 to 11 on 45mg/day. - A case from Dr. Tess Lawry showed CA125 (ovarian cancer marker) drop from 288 to 22 on just 0.2mg/kg. - A long-term Castro study on children with leukemia showed no side effects after 6 months at 1mg/kg. For aggressive cancers (pancreatic, brain), the blood-brain barrier may require a higher dose. Dr. Makis cites: - Dr. Landrito's colleague with terminal gallbladder cancer: cancer disappeared after 14 months at 2mg/kg/day. - The highest documented dose is 2.5mg/kg (Dr. Chetty), with only transient visual side effects that resolved. Mainstream oncology will not offer this. Why? Ivermectin is generic, off-patent, and unprofitable. Consequently, there are no funded clinical trials. Dr. Makis's powerful conclusion: "Using ivermectin in cancer is honestly very straightforward. It is a very, very safe drug." His strong suggestion for those struggling: start at 1mg/kg/day. It can be taken for many months, even over a year, with an excellent safety profile based on long-term anecdotal evidence. The power to fight may already be on your shelf.

Camus

838,854 Aufrufe • vor 1 Jahr

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs

🚨 DR. WILLIAM MAKIS REVEALED THE IVERMECTIN DOSING STRATEGY HE'S USING IN CANCER PATIENTS. HERE'S WHAT HE'S SEEING. In a recent discussion, Dr. William Makis was asked a question many cancer patients are now researching: 📌 How does he use Ivermectin in cancer protocols? His answer surprised a lot of people. For most intermediate to high-grade cancers, Dr. Makis said his typical starting dose is: 💊 1 mg/kg per day For a 60 kg (132 lb) person, that's approximately: 📊 60mg daily According to him, that's roughly 5 times higher than the dose commonly used for parasitic infections. For lower-grade cancers, he often starts lower: 💊 0.5 mg/kg per day Examples discussed included: • Chronic Lymphocytic Leukemia (CLL) • Multiple Myeloma For a 60 kg person, that would be about: 📊 30mg daily And unlike many protocols circulating online, he noted that the dosing is typically: 📅 7 days per week But the dosage wasn't the part that got my attention. The timeline was. According to Dr. Makis, some patients may begin seeing changes in cancer markers within: ⏳ 3 to 4 weeks He specifically mentioned markers such as: 📉 PSA 📉 CEA 📉 CA-125 📉 Other cancer-related markers He explained that these markers can sometimes provide an early indication that something is changing before tumors physically shrink. Then come the scans. According to his experience: 📊 PET scans may begin showing reduced cancer activity within about a month. 📊 Physical tumor shrinkage often becomes visible after roughly 2 to 3 months on PET-CT, CT, or MRI imaging. That's why he generally recommends giving a protocol: ⏳ A full 3 months Before evaluating whether a meaningful response is occurring. But perhaps the most surprising statement came near the end. Dr. Makis said the best results he has personally seen were not necessarily from Ivermectin alone. According to him, some of the most dramatic responses occurred when patients combined: 💊 Ivermectin PLUS 💊 Chemotherapy That observation is likely to spark debate from every side of the conversation. Whether you agree with his conclusions or not, one thing is clear: More patients are reading studies. More doctors are discussing repurposed medicines. And more people are asking questions that weren't being asked a few years ago. That's why conversations around Ivermectin continue to grow across cancer communities worldwide. 🌐 Looking for Ivermectin, Fenbendazole, or Mebendazole? Explore RXMEDS.STORE. #Ivermectin #WilliamMakis #CancerResearch #CancerProtocol #RepurposedDrugs

RXMEDS.STORE

37,349 Aufrufe • vor 2 Monaten

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch

🚨 WHY IVERMECTIN DOSING ISN'T ONE SIZE FITS ALL. THIS PHYSICIAN EXPLAINS THE DIFFERENCE. A physician starts with a point that many people overlook: Ivermectin dosing is weight based. So before discussing any amount, she starts with body weight. 📌 Her conversion: Weight in pounds ÷ 2.2 = kilograms Her example: 130 lb ÷ 2.2 ≈ 59 kg But that's only the starting point. She then explains that the amount she discusses changes depending on what Ivermectin is being used for. 💊 PREVENTION 0.2 mg/kg twice a week 💊 PARASITE CLEANSE 0.3 mg/kg She says she then follows the protocol associated with her parasite cleanse. 💊 COVID, FLU OR RSV She describes a range of: 0.4 to 0.6 mg/kg She also explains that she may round the calculated amount upward to an even 5 mg increment. Then comes the most variable category. 💊 CANCER She says the amount can depend on: • Cancer type • Cancer stage • Disease progression • How aggressive the approach is She says she may go as high as: 📈 1 mg/kg or higher Then she gives the principle behind her entire explanation: "It just depends on what you're doing it for." And the lowest amount she says she would use? 📌 0.2 mg/kg But the bigger takeaway from this discussion is simple: Ivermectin dosing depends on what it is being used for, not just body weight. And simply converting pounds to kilograms and applying a number isn't enough to determine an appropriate treatment plan. Indication, formulation, other medications, medical history, and safety all matter. Ivermectin has a long history of human use, but higher doses can increase the risk of adverse effects. The FDA also distinguishes human ivermectin products from veterinary formulations, which are not substitutes for medicines intended for people. And when the indication is experimental, particularly cancer, the dosing question is something clinical research still needs to answer. 📌 Save this post if you're researching Ivermectin dosing and want to understand why there isn't one universal number. 🔄 Repost it so others researching Ivermectin can see the discussion. 💊 Exploring Ivermectin? See why thousands of customers worldwide choose RXMEDS.STORE for pharmaceutical grade Ivermectin. #Ivermectin #IvermectinDosage #IvermectinResearch #RepurposedDrugs #MedicalResearch

RXMEDS.STORE

33,299 Aufrufe • vor 12 Tagen

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin

🚨 DR. ANTONIO JIMENEZ ON NATURAL APPROACHES TO CANCER Dr. Antonio Jimenez, who runs clinics in Tijuana and Cancun, has been treating cancer patients naturally for over 35 years. He claims to have helped people with almost every type of cancer. One of the approaches he recommends is food-grade hydrogen peroxide taken orally. According to him, cancers are often linked to parasites or venoms, and hydrogen peroxide may help address both. He suggests starting with a low dose: Begin with 3 to 4 drops of 6% food-grade hydrogen peroxide in 6 to 8 ounces of water. Gradually increase the number of drops over time, up to around 20 drops per day. He references the book The One Minute Cure, which shares stories of people who reportedly overcame terminal cancers using this method. Whether you agree with this approach or not, one thing is clear. More practitioners and patients are exploring natural and alternative protocols for cancer, and these discussions are growing online. Visit PharmacyinUSA to access Ivermectin, Fenbendazole, and Mebendazole with worldwide delivery. #HydrogenPeroxide #Cancer #AlternativeHealth #Ivermectin

PharmacyinUSA

45,592 Aufrufe • vor 1 Monat

🚨 IVERMECTIN IS EVERYWHERE AGAIN… HERE’S WHY PEOPLE KEEP ASKING ABOUT IT The internet is flooded with dosing guides, “protocols,” and self-experimentation stories. Why it’s trending: ✅ Long history as an anti-parasitic medication ✅ Widely discussed in wellness and alternative health circles ✅ Some claim broader off-label benefits But here’s what matters: ⚠️ Veterinary ivermectin products are not formulated for human use and can be dangerous due to concentration and inactive ingredients. The bigger takeaway: Interest in repurposed drugs is exploding… but so is misinformation. ⚠️ Not a medical advise, Consult your doctor before taking any medications. #Ivermectin #CancerCure #PharmacyinUSA

🚨 IVERMECTIN IS EVERYWHERE AGAIN… HERE’S WHY PEOPLE KEEP ASKING ABOUT IT The internet is flooded with dosing guides, “protocols,” and self-experimentation stories. Why it’s trending: ✅ Long history as an anti-parasitic medication ✅ Widely discussed in wellness and alternative health circles ✅ Some claim broader off-label benefits But here’s what matters: ⚠️ Veterinary ivermectin products are not formulated for human use and can be dangerous due to concentration and inactive ingredients. The bigger takeaway: Interest in repurposed drugs is exploding… but so is misinformation. ⚠️ Not a medical advise, Consult your doctor before taking any medications. #Ivermectin #CancerCure #PharmacyinUSA

PharmacyinUSA

34,452 Aufrufe • vor 4 Monaten

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

PharmacyinUSA

12,063 Aufrufe • vor 1 Monat

🚨 THE “HORSE DEWORMER” THEY MOCKED JUST HIT 25 MILLION VIEWS IN DAYS People are paying attention again. Not because of headlines. Not because of pharma ads. Not because TV told them to. Because people are searching for answers themselves. Why Ivermectin keeps coming back into the conversation: ✅ Nobel Prize winning discovery in 2015 for parasitic disease research. ✅ Decades of worldwide human use ✅ Massive public interest in repurposed medicine ✅ Millions openly discussing personal experiences online And the biggest reason? People feel like the public conversation around affordable repurposed drugs was shut down instead of openly debated. Whether critics like it or not: The internet is FULL of people sharing stories, protocols, questions, and experiences. But it does prove one thing: The public never stopped searching for alternatives. ⚠️ Not a medical advice #Ivermectin #HorseDewormer #Cancer #BigPharma

🚨 THE “HORSE DEWORMER” THEY MOCKED JUST HIT 25 MILLION VIEWS IN DAYS People are paying attention again. Not because of headlines. Not because of pharma ads. Not because TV told them to. Because people are searching for answers themselves. Why Ivermectin keeps coming back into the conversation: ✅ Nobel Prize winning discovery in 2015 for parasitic disease research. ✅ Decades of worldwide human use ✅ Massive public interest in repurposed medicine ✅ Millions openly discussing personal experiences online And the biggest reason? People feel like the public conversation around affordable repurposed drugs was shut down instead of openly debated. Whether critics like it or not: The internet is FULL of people sharing stories, protocols, questions, and experiences. But it does prove one thing: The public never stopped searching for alternatives. ⚠️ Not a medical advice #Ivermectin #HorseDewormer #Cancer #BigPharma

PharmacyinUSA

344,360 Aufrufe • vor 3 Monaten

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

🚨 THIS WAS NEVER SUPPOSED TO BE A CANCER DRUG Fenbendazole was developed to treat parasites. Not cancer. Which is why researchers were surprised enough to publish a case series describing three patients whose cancers reportedly went into remission after using it. Cancer survives by dividing over and over again. Fenbendazole appears to interfere with microtubules, structures cells need to complete that process. The paper doesn't claim fenbendazole is a cure. But it does explain why this decades-old antiparasitic keeps showing up in cancer discussions around the world. And once people start reading the studies for themselves, the next question usually isn't "Does this exist?" It's "Where can I get it?" That's why thousands turn to PharmacyinUSA for fenbendazole, ivermectin, and other repurposed medicines.

PharmacyinUSA

14,784 Aufrufe • vor 2 Monaten

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 Aufrufe • vor 1 Jahr

According to Dr. William Makis, high-dose ivermectin shows tremendous promise for treating a majority of cancers. The required dose is significant – about 1mg/kg, or 60mg daily for a 60kg person – far higher than what was discussed for COVID-19. So why isn't this being rushed into clinical trials? The answer, Dr. Makis reveals, is a story of profit over patients. Ivermectin is off-patent. No pharmaceutical company can monopolize profits from it, so they have no incentive to fund research. In a stunning revelation, Dr. Makis connects the dots: Merck, the original patent holder, actively badmouthed ivermectin during COVID. The reason? They are in a 50-50 partnership with Moderna on a new mRNA cancer vaccine. Pushing a cheap, generic cure would directly threaten their future billion-dollar profits. But the story doesn't end there. Dr. Makis also highlights the power of repurposed anti-parasitics like fenbendazole and its FDA-approved human version, mebendazole. These drugs work by upregulating p53, a critical tumor suppressor protein. This is crucial because emerging research suggests the COVID-19 vaccine spike protein may downregulate p53, a potential mechanism for the turbo-cancers being observed. Treatments like mebendazole offer a direct counter to this effect, something conventional chemo and radiation do not. The solution? Dr. Makis advocates for public policy that directs government cancer funding toward off-patent, repurposed drugs. This takes the politics and profiteering out of the equation, allowing science to focus on what truly matters: saving lives.

According to Dr. William Makis, high-dose ivermectin shows tremendous promise for treating a majority of cancers. The required dose is significant – about 1mg/kg, or 60mg daily for a 60kg person – far higher than what was discussed for COVID-19. So why isn't this being rushed into clinical trials? The answer, Dr. Makis reveals, is a story of profit over patients. Ivermectin is off-patent. No pharmaceutical company can monopolize profits from it, so they have no incentive to fund research. In a stunning revelation, Dr. Makis connects the dots: Merck, the original patent holder, actively badmouthed ivermectin during COVID. The reason? They are in a 50-50 partnership with Moderna on a new mRNA cancer vaccine. Pushing a cheap, generic cure would directly threaten their future billion-dollar profits. But the story doesn't end there. Dr. Makis also highlights the power of repurposed anti-parasitics like fenbendazole and its FDA-approved human version, mebendazole. These drugs work by upregulating p53, a critical tumor suppressor protein. This is crucial because emerging research suggests the COVID-19 vaccine spike protein may downregulate p53, a potential mechanism for the turbo-cancers being observed. Treatments like mebendazole offer a direct counter to this effect, something conventional chemo and radiation do not. The solution? Dr. Makis advocates for public policy that directs government cancer funding toward off-patent, repurposed drugs. This takes the politics and profiteering out of the equation, allowing science to focus on what truly matters: saving lives.

Camus

88,873 Aufrufe • vor 9 Monaten

Oncologist Dr. William Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics, and they respond very well... [And] why do these antiparasitics work?" Todd Callender: "Cancer's a parasite?" Makis: "That's one possibility." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with attorney Todd Callender posted to the VaxxCHOICE (VaxxCHOICE) Rumble channel on November 21, 2025. ---------------Partial transcription of clip---------------- Dr. Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics and they respond very well. This is, you know, whether it's ivermectin, fenbendazole or mebendazole, these patients are responding. "Now this is very important because patients who've developed cancer after taking Covid vaccines, they don't respond usually to conventional treatments. That's one of the hallmarks of turbo cancer is they present at a very late stage. These are extremely rapidly growing tumors. They're coming in at stage four. And it's whether it's young women with breast cancer, women in their 20s, something we've never seen before, young women with, men and women with colon cancer in their 20s and 30s. "Again, we've never seen—" Callender: "Two- year-olds, I've heard of two- year-olds with colon cancer—" Dr. Makis: "—we've never seen this before. That's the incredible part. And they're not responding to conventional treatments. So, they're not responding to chemo, they're not responding to radiation therapy, immunotherapy, or if they do response, they have a very, very short response time or remission time. And then the cancer comes roaring back. "And in a lot of these tragic cases, the patient dies within six months. This is another one of the features of turbo cancer is the prognosis is extremely poor if you go the conventional route. So you need something else. Now when you're using antiparasitics, for cancer, the dose is higher than the dose you would use to treat parasites or to treat Covid. So I give just a rule of thumb for ivermectin, for example, it's about five times the dose that you would need for cancer, about 5 to 10 times the dose than if you were just treating parasites or viruses. "And to go into the— why does it work? Why do these antiparasitics work?" Callender: "Cancer's a parasite?" Dr. Makis: "Well, that's one possibility. But there's more to it than that because, out of the 400 papers that have been published, a lot of those researchers look at the mechanisms. They are trying to identify the mechanisms of how ivermectin is treating these cancers. "And you've got, for example, there was one study published a few years ago, Mexican researchers, again, you're not going to see this done in the United States, Mexico. Mexican researchers took 28 different cancer cell lines, applied ivermectin to them, and all of them responded. Now to various degrees, you had breast cancer and ovarian cancer actually responding the most to ivermectin. You had the most cancer cell killing when they were exposed to ivermectin. "But when they look at the mechanisms, they've identified a number of interesting things. For example, ivermectin shuts down and kills cancer stem cells. Now, this is important because cancer stem cells are the reason chemotherapy doesn't work. When you have stage four pancreatic cancer, stage four ovarian cancer, and you go to your oncologist, they will tell you, we will give you chemo, but we can't cure you. It's palliative chemo. It'll buy you an extra six months, an extra 12 months of life. "The reason why they say that is why the chemo is palliative, not curative. It's is because chemo cannot kill cancer stem cells, which are not rapidly dividing. Chemo will kill everything that's rapidly dividing, but cancer stem cells are not rapidly dividing. And so the chemo will kill the rapidly dividing tumor cells, and it'll leave the cancer stem cells alone, while the cancer stem cells will start rapidly dividing a year later, two years later, they're going to spread to other parts of the body. Suddenly you've got recurrence, you've got metastases. Ivermectin will shut down and kill cancer stem cells. "So imagine you, added to your chemo regimen, and now you've essentially turned what's palliative chemo or a palliative situation to potentially a curative situation. And I really do believe I've come to the point, having helped over 7,000 cancer patients in the last year, I've come to the point where I could confidently say that stage 4 pancreatic cancer is curable, stage 4 ovarian cancer is curable, stage 4 colon cancer, lung cancer. These cancers are curable. I think if you add repurposed drugs, you add antiparasitics, you can turn these into curable situations. "Now, of course, we have to prove that. We have to do the research, do the publications. But in the meantime, I say stage 4 cancer patients don't have 10 years to wait for mainstream oncology or mainstream medicine to catch up with what we're seeing already clinically, in practice."

Oncologist Dr. William Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics, and they respond very well... [And] why do these antiparasitics work?" Todd Callender: "Cancer's a parasite?" Makis: "That's one possibility." This clip of Dr. Makis (William Makis), a radiologist, oncologist, and cancer researcher, is taken from an interview with attorney Todd Callender posted to the VaxxCHOICE (VaxxCHOICE) Rumble channel on November 21, 2025. ---------------Partial transcription of clip---------------- Dr. Makis: "The turbo cancers after the COVID vaccines do respond to the antiparasitics and they respond very well. This is, you know, whether it's ivermectin, fenbendazole or mebendazole, these patients are responding. "Now this is very important because patients who've developed cancer after taking Covid vaccines, they don't respond usually to conventional treatments. That's one of the hallmarks of turbo cancer is they present at a very late stage. These are extremely rapidly growing tumors. They're coming in at stage four. And it's whether it's young women with breast cancer, women in their 20s, something we've never seen before, young women with, men and women with colon cancer in their 20s and 30s. "Again, we've never seen—" Callender: "Two- year-olds, I've heard of two- year-olds with colon cancer—" Dr. Makis: "—we've never seen this before. That's the incredible part. And they're not responding to conventional treatments. So, they're not responding to chemo, they're not responding to radiation therapy, immunotherapy, or if they do response, they have a very, very short response time or remission time. And then the cancer comes roaring back. "And in a lot of these tragic cases, the patient dies within six months. This is another one of the features of turbo cancer is the prognosis is extremely poor if you go the conventional route. So you need something else. Now when you're using antiparasitics, for cancer, the dose is higher than the dose you would use to treat parasites or to treat Covid. So I give just a rule of thumb for ivermectin, for example, it's about five times the dose that you would need for cancer, about 5 to 10 times the dose than if you were just treating parasites or viruses. "And to go into the— why does it work? Why do these antiparasitics work?" Callender: "Cancer's a parasite?" Dr. Makis: "Well, that's one possibility. But there's more to it than that because, out of the 400 papers that have been published, a lot of those researchers look at the mechanisms. They are trying to identify the mechanisms of how ivermectin is treating these cancers. "And you've got, for example, there was one study published a few years ago, Mexican researchers, again, you're not going to see this done in the United States, Mexico. Mexican researchers took 28 different cancer cell lines, applied ivermectin to them, and all of them responded. Now to various degrees, you had breast cancer and ovarian cancer actually responding the most to ivermectin. You had the most cancer cell killing when they were exposed to ivermectin. "But when they look at the mechanisms, they've identified a number of interesting things. For example, ivermectin shuts down and kills cancer stem cells. Now, this is important because cancer stem cells are the reason chemotherapy doesn't work. When you have stage four pancreatic cancer, stage four ovarian cancer, and you go to your oncologist, they will tell you, we will give you chemo, but we can't cure you. It's palliative chemo. It'll buy you an extra six months, an extra 12 months of life. "The reason why they say that is why the chemo is palliative, not curative. It's is because chemo cannot kill cancer stem cells, which are not rapidly dividing. Chemo will kill everything that's rapidly dividing, but cancer stem cells are not rapidly dividing. And so the chemo will kill the rapidly dividing tumor cells, and it'll leave the cancer stem cells alone, while the cancer stem cells will start rapidly dividing a year later, two years later, they're going to spread to other parts of the body. Suddenly you've got recurrence, you've got metastases. Ivermectin will shut down and kill cancer stem cells. "So imagine you, added to your chemo regimen, and now you've essentially turned what's palliative chemo or a palliative situation to potentially a curative situation. And I really do believe I've come to the point, having helped over 7,000 cancer patients in the last year, I've come to the point where I could confidently say that stage 4 pancreatic cancer is curable, stage 4 ovarian cancer is curable, stage 4 colon cancer, lung cancer. These cancers are curable. I think if you add repurposed drugs, you add antiparasitics, you can turn these into curable situations. "Now, of course, we have to prove that. We have to do the research, do the publications. But in the meantime, I say stage 4 cancer patients don't have 10 years to wait for mainstream oncology or mainstream medicine to catch up with what we're seeing already clinically, in practice."

Sense Receptor

96,616 Aufrufe • vor 9 Monaten